Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Sherman

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Oral Oncology|May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancerAntoine Desilets, David G Pfister, Sarah Stein, et al.
Cancer|December 22, 2016
Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancerZachary S Zumsteg, Sungjin Kim, John M David, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2012
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinomaEric J Sherman, Yungpo Bernard Su, Ashima Lyall, et al.
The Laryngoscope|March 1, 2012
TALK score: Development and validation of a prognostic model for predicting larynx preservation outcomeEric J Sherman, Susan G Fisher, Dennis H Kraus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic reviewEric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Histopathology|August 27, 2021
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 casesBin Xu, Julia David, Snjezana Dogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusionSnjezana Dogan, Lu Wang, Ryan N Ptashkin, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Journal of Surgical Oncology|November 17, 2019
Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinomaAndries H Groen, Thomas H Beckham, Thera P Links, et al.
Head & Neck|February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studiesNoel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Oral Oncology|May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancerAntoine Desilets, David G Pfister, Sarah Stein, et al.
Cancer|December 22, 2016
Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancerZachary S Zumsteg, Sungjin Kim, John M David, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2012
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinomaEric J Sherman, Yungpo Bernard Su, Ashima Lyall, et al.
The Laryngoscope|March 1, 2012
TALK score: Development and validation of a prognostic model for predicting larynx preservation outcomeEric J Sherman, Susan G Fisher, Dennis H Kraus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic reviewEric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Histopathology|August 27, 2021
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 casesBin Xu, Julia David, Snjezana Dogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusionSnjezana Dogan, Lu Wang, Ryan N Ptashkin, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Journal of Surgical Oncology|November 17, 2019
Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinomaAndries H Groen, Thomas H Beckham, Thera P Links, et al.
Head & Neck|February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studiesNoel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
Pageof 12